Grey Matters Health Inc. (AGNPF)
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Grey Matters Health Inc.
OTC:AGNPFHealthcare · Biotechnology
-9.60%$0.2403
Mkt Cap$1.94M
Float4.61M
O/S8.06M
Vol
$ Vol
RVOL
Inst Own-
SI<0.1%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$1.23M
Total Assets$3.49M
Free Cash Flow-$828K
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$1.93M
Shares Outstanding
Short Interest
Split History3 splits · 2 reverse
2-year cumulative
1:10
Nasdaq bars a compliance period at 1:250
- 1:10Reverse splitApr 21, 202610 shares → 1
- 4:1Forward splitMar 3, 20231 share → 4
- 1:100Reverse splitNov 24, 2021100 shares → 1
Balance Sheet Details
Assets$3.49M
Liabilities$1.56M
Accounts Receivable$12K
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$3.07M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $39K | $0 | $36K | $25K | $0 | $0 | $19K | $29K | $0 | $0 | $0 |
| Gross Profit | -$39K | $0 | -$36K | -$25K | $0 | $0 | -$19K | -$29K | -$92K | -$34K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $40K | $466K | $784K | $1.64M | $3.43M | $1.91M | $434K | $67K | $254K | $140K | $130K |
| Selling, General, and Administrative | $1.15M | $1.18M | $2.82M | $2.67M | $2.33M | $4.29M | $850K | $577K | $785K | $1.88M | $393K |
| Other | -$193 | -$112 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $1.19M | $1.65M | $3.59M | $4.31M | $5.76M | $6.2M | $1.37M | $644K | $1.04M | $2.1M | $523K |
| Operating Income (EBIT) | -$1.23M | -$1.65M | -$3.59M | -$4.38M | -$7.04M | -$6.73M | -$1.28M | -$644K | -$998K | -$2.1M | -$523K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $528 | $979 | $2K | $1K | $9K | $25K | $5K | $8K | $5K | $5K | $0 |
| Other Income (Expense) | $528 | $1.29M | -$1.26M | -$26K | $1.51M | $615K | $8K | -$28K | -$355K | -$2.82M | $414 |
| Income Before Tax (EBT) | -$1.23M | -$360K | -$4.85M | -$4.33M | -$5.54M | -$6.11M | -$1.36M | -$671K | -$1.35M | -$4.92M | -$523K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$13K | $0 | $0 | -$5K | $0 |
| Net Income | -$1.23M | -$360K | -$4.85M | -$4.33M | -$5.54M | -$6.11M | -$1.36M | -$671K | -$1.35M | -$4.92M | -$523K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -0.58 | -0.25 | -4.50 | -8.70 | -12.40 | -24.20 | -10.60 | -8.30 | -18.40 | -97.50 | -34.90 |
| Diluted EPS | -0.58 | -0.25 | -4.50 | -8.70 | -12.40 | -24.20 | -10.60 | -8.30 | -18.40 | -97.50 | -34.80 |
| Weighted Average OS | 2.95M | 2.00M | 1.51M | 695,200 | 743,600 | 420,500 | 178,600 | 112,600 | 102,600 | 70,500 | 20,900 |
| EBITDA | -$1.39M | -$1.63M | -$3.57M | -$4.09M | -$135 | -$6.03M | -$1.26M | -$614K | -$907K | -$1.98M | $336 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $126K | $427K | $90K | $1.01M | $1.73M | $4.38M | $149K | $896K | $997K | $1.14M | $1M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $126K | $427K | $90K | $1.01M | $1.73M | $4.38M | $149K | $896K | $997K | $1.14M | $1M |
| Accounts Receivable | $12K | $11K | $69K | $476K | $1.64M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $476K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $397K | $529K | $243K | $2.02M | $3.51M | $5.54M | $200K | $927K | $1.05M | $1.23M | $1M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39K | $49K | $20K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $3.07M | $2.27M | $2.72M | $3.76M | $3.7M | $3.6M | $3.58M | $52K | $70K | $381K | $0 |
| Long-Term Investments | $21K | $0 | $0 | $41K | $41K | $41K | $41K | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $193 | $21K | $41K | $0 | $0 | $0 | $981 | $981 | $981 | $981 | $981 |
| Total Long-Term Assets | $3.09M | $2.29M | $2.76M | $3.8M | $3.74M | $3.64M | $3.62M | $92K | $119K | $402K | $981 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3.49M | $2.82M | $3M | $5.83M | $7.26M | $9.18M | $3.82M | $1.02M | $1.17M | $1.63M | $1M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $0 | $1.25M | $0 | $2K | $732 | $435 | $0 | $0 | $0 | $0 | $124K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.56M | $0 | $1.95M | $0 | $731K | $0 | $261K | $41K | $34K | $108K | $0 |
| Total Current Liabilities | $1.56M | $1.27M | $1.95M | $1.8M | $732K | $435K | $262K | $41K | $34K | $108K | $124K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.56M | $1.27M | $1.95M | $1.8M | $732K | $435K | $262K | $41K | $34K | $108K | $124K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $21.58M | $21.16M | $20.15M | $19.41M | $18.51M | $15.28M | $9.01M | $6.13M | $5.72M | $5.18M | $1.1M |
| Retained Earnings | -$21.87M | -$22.02M | -$22.04M | -$18.03M | -$16.86M | -$12.5M | -$7.35M | -$6.39M | -$6.32M | -$5.23M | -$305K |
| Comprehensive Income & Other | $2.21M | $2.41M | $2.95M | $2.65M | $4.88M | $5.97M | $1.9M | $1.24M | $1.73M | $92K | $89K |
| Other Stockholders' Equity | $2.21M | $2.41M | $2.95M | $2.65M | $4.88M | $5.97M | $1.9M | $1.24M | $1.73M | $1.57M | $89K |
| Total Equity | $1.93M | $1.55M | $1.06M | $4.03M | $6.53M | $8.75M | $3.56M | $978K | $1.14M | $1.52M | $879K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $3.49M | $2.82M | $3M | $5.83M | $7.26M | $9.18M | $3.82M | $1.02M | $1.17M | $1.63M | $1M |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$126K | -$427K | -$90K | -$1.01M | -$1.73M | -$4.38M | -$149K | -$896K | -$997K | -$1.14M | -$1M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 |
| Operating Activities | |||||||||||
| Net Income | -$1.23M | -$360K | -$4.85M | -$4.33M | -$5.54M | -$6.11M | -$1.36M | -$671K | -$1.35M | -$4.92M | -$523K |
| Depreciation & Amortization | $39K | $19K | $36K | $25K | $5.64M | $19K | $19K | $29K | $91K | $34K | $523K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $326K | -$981 | $0 |
| Stock-Based Compensation | $140K | $205K | $900K | $380K | $592K | $2.28M | $0 | $168K | $99K | $1.05M | $0 |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | -$997 | $58K | $406K | $1.16M | -$824K | -$804K | $8K | -$1K | $18K | -$25K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $185K | -$499K | $500K | $694K | $396K | $39K | $59K | $33K | -$72K | $24K | $0 |
| Total Working Capital Change | $184K | -$441K | $906K | $1.85M | -$428K | -$765K | $67K | $31K | -$54K | -$342 | $0 |
| Other Non-Cash Items | $178K | -$1.36M | $1.18M | -$6K | -$5.87M | -$150K | -$5K | $1K | $343K | $2.83M | -$242K |
| Net Cash from Operating | -$828K | -$1.94M | -$1.83M | -$2.09M | -$5.6M | -$4.73M | -$1.28M | -$441K | -$874K | -$1.01M | -$241K |
| Investing Activities | |||||||||||
| Capital Expenditures | -$18K | -$60K | -$43K | -$104K | -$89K | -$71K | -$47K | $0 | -$62K | -$92K | $0 |
| Acquisitions | $125K | $0 | $0 | $0 | $0 | $0 | $72K | $0 | $19K | $1.1M | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $125K | $1.69M | -$43K | -$104K | -$89 | -$71 | $40K | $0 | $19K | -$70K | -$2K |
| Net Cash from Investing | $107K | $1.63M | -$43K | -$104K | -$89K | -$71K | $65K | $0 | -$43K | $1.01M | -$2K |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $420K | $640K | $878K | $1.47M | $1.93M | $6.63M | $354K | $338K | $772K | $132K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $5K | $74K | $1.47M | $1.11M | $2.41M | $110K | $338K | $0 | $132K | $1.88M |
| Net Cash from Financing | $420K | $645K | $951K | $1.47M | $3.04M | $9.03M | $464K | $338K | $772K | $132K | $1.88M |
| Forex Effect | -$8K | -$248 | $125 | -$306 | -$6K | $3K | $586 | $2K | -$2K | $4K | $84K |
| Net Change in Cash | -$308K | $337K | -$919K | -$718K | -$2.66M | $4.23M | -$747K | -$101K | -$147K | $142K | $1.72M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$828K | -$1.94M | -$1.83M | -$2.09M | -$5.6M | -$4.73M | -$1.28M | -$441K | -$874K | -$1.01M | -$241K |
| Capital Expenditure | -$18K | -$60K | -$43K | -$104K | -$89K | -$71K | -$47K | $0 | -$62K | -$92K | $0 |
| Free Cash Flow | -$828K | -$2M | -$1.87M | -$2.19M | -$5.69M | -$4.8M | -$1.32M | -$441K | -$936K | -$1.1M | -$241K |
| Cash at Beginning | $434K | $90K | $1.01M | $1.73M | $4.38M | $149K | $896K | $997K | $1.14M | $1M | -$1.72M |
| Cash at End | $126K | $427K | $90K | $1.01M | $1.73M | $4.38M | $149K | $896K | $997K | $1.14M | $2K |